| P50 | author | Caterina Rosano | Q51929723 |
| | John P Ryan | Q59701398 |
| P2093 | author name string | David F Fine | |
| P2860 | cites work | Alzheimer Disease in the US Population | Q22253055 |
| | Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study | Q24628969 |
| | Neuropathological stageing of Alzheimer-related changes | Q27860862 |
| | Glucagon-like peptide-1 receptor is involved in learning and neuroprotection | Q28202403 |
| | Functional connectivity in the resting brain: a network analysis of the default mode hypothesis | Q29547875 |
| | Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. | Q32050146 |
| | Tracking Alzheimer's disease | Q33281339 |
| | Human cerebral neuropathology of Type 2 diabetes mellitus | Q33710643 |
| | Brain graphs: graphical models of the human brain connectome | Q33762560 |
| | Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status | Q33927061 |
| | Characterizing variation in the functional connectome: promise and pitfalls | Q34160885 |
| | Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study | Q34467303 |
| | Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology | Q35184690 |
| | Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial | Q35679839 |
| | Epidemiology of Alzheimer disease | Q35920548 |
| | Impairments in cognition and resting-state connectivity of the hippocampus in elderly subjects with type 2 diabetes | Q48324484 |
| | Diabetes is related to cerebral infarction but not to AD pathology in older persons | Q48342090 |
| | Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype | Q48555125 |
| | Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetes | Q48558337 |
| | Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes | Q48603149 |
| | Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study | Q48864941 |
| | The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. | Q51011184 |
| | Alzheimer's disease: a global challenge for the 21st century. | Q53406047 |
| | Should we target insulin resistance to prevent dementia due to Alzheimer disease? | Q53420396 |
| | Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors | Q63437223 |
| | Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow | Q73550298 |
| | Type 2 diabetes: pathogenesis and treatment | Q81541542 |
| | Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis | Q35960169 |
| | Baseline cardiovascular risk predicts subsequent changes in resting brain function | Q35992284 |
| | Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging | Q36078724 |
| | Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus | Q36142942 |
| | Resting-state brain functional connectivity is altered in type 2 diabetes | Q36182522 |
| | Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies | Q36311526 |
| | Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies | Q36477870 |
| | Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. | Q36477892 |
| | Session III: Mechanisms of age-related cognitive change and targets for intervention: inflammatory, oxidative, and metabolic processes | Q36507307 |
| | Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults | Q36560342 |
| | Amyloid-β induces hepatic insulin resistance in vivo via JAK2. | Q36720621 |
| | Cerebral perfusion in relation to cognitive function and type 2 diabetes | Q36738251 |
| | Molecular connexions between dementia and diabetes. | Q36837972 |
| | Cognition and diabetes: a lifespan perspective. | Q37061183 |
| | Increased risk of cognitive impairment in patients with diabetes is associated with metformin | Q37193677 |
| | Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition | Q37291871 |
| | Brain atrophy in type 2 diabetes: regional distribution and influence on cognition | Q37331270 |
| | Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus | Q37358847 |
| | Emotional and neutral declarative memory impairments and associated white matter microstructural abnormalities in adults with type 2 diabetes. | Q37457090 |
| | A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus | Q37463920 |
| | Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging | Q37603091 |
| | How does diabetes accelerate Alzheimer disease pathology? | Q37788954 |
| | Cognitive function, dementia and type 2 diabetes mellitus in the elderly | Q37832122 |
| | An update on type 2 diabetes, vascular dementia and Alzheimer's disease | Q38033909 |
| | Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study | Q38433563 |
| | Altered baseline brain activity in type 2 diabetes: a resting-state fMRI study | Q39399317 |
| | Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance | Q40803943 |
| | Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. | Q41841220 |
| | Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study | Q44779259 |
| | Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort | Q44958565 |
| | Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64-year-old community sample | Q45848886 |
| | Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin | Q46428482 |
| | Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic | Q46800282 |
| | Intranasal insulin improves cognition and modulates beta-amyloid in early AD. | Q46945303 |
| | Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. | Q47408299 |
| | Regional cerebral blood flow in diabetic patients: evaluation by N-isopropyl-123I-IMP with SPECT. | Q48110806 |
| | Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus | Q48247759 |
| | Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes | Q48255137 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuroimaging | Q551875 |
| | type 2 diabetes | Q3025883 |
| | cognitive dysfunction | Q57859955 |
| P304 | page(s) | 47-55 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | Journal of Geriatric Psychiatry and Neurology | Q6295256 |
| P1476 | title | Type 2 diabetes and cognitive impairment: contributions from neuroimaging | |
| P478 | volume | 27 | |